about
Hospitalization Risk Due to Respiratory Illness Associated with Genetic Variation at IFITM3 in Patients with Influenza A(H1N1)pdm09 Infection: A Case-Control Study.A remarkable depletion of both naïve CD4+ and CD8+ with high proportion of memory T cells in an IPEX infant with a FOXP3 mutation in the forkhead domain.Low frequency of CD4+CD25+ Treg in SLE patients: a heritable trait associated with CTLA4 and TGFbeta gene variants.Slc25a12 disruption alters myelination and neurofilaments: a model for a hypomyelination syndrome and childhood neurodevelopmental disordersCompensatory T-cell regulation in unaffected relatives of SLE patients, and opposite IL-2/CD25-mediated effects suggested by coreferentiality modeling.Genetic variation at the CYP2C19 gene associated with metabolic syndrome susceptibility in a South Portuguese population: results from the pilot study of the European Health Examination Survey in Portugal.Pharmacogenetic profile of a South Portuguese population: results from the pilot study of the European Health Examination Survey in Portugal.Autoantibody repertoires to brain tissue in autism nuclear families.Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus.Prevalence of overweight and obesity in Portugal: Results from the First Portuguese Health Examination Survey (INSEF 2015).Prevalence, awareness, treatment and control of diabetes in Portugal: Results from the first National Health examination Survey (INSEF 2015).Factors associated to repeated influenza vaccination in the Portuguese adults with chronic conditionsHeritable factors shape natural human IgM reactivity to Ro60/SS-A and may predispose for SLE-associated IgG anti-Ro and anti-La autoantibody productionThe first Portuguese National Health Examination Survey (2015): design, planning and implementationDifferential self-report error by socioeconomic status in hypertension and hypercholesterolemia: INSEF 2015 studyOral hygiene habits in Portugal: results from the first Health Examination Survey (INSEF 2015)
P50
Q30389881-A1BAEA3F-3349-4D49-A7B7-1645A65F03F0Q33379659-EAB4D2FF-BA33-4E4F-9297-66893240C636Q33403373-A9318D8E-040B-460A-8A57-4B3BDC175293Q33794500-1E5E47F4-76BC-41DE-85DC-582D5F9F92D4Q34221885-3EDE12B8-EBDD-48E4-BFEB-F008D1E386FFQ37599633-79C2541A-6BC0-43BF-B9D6-89E8B0302CDAQ41232932-07DCAAB6-A0EB-415A-875F-55DDE4CA9EE9Q44956144-C43F3FF7-5AD1-4BBF-9235-15ACC480CDF2Q47618195-EE485D06-71EB-4DC2-A0DE-7C181838F6F9Q50063538-99660059-0FB9-4D39-9DAE-DC6C32627408Q52601381-475217A1-CE0A-4878-9A17-D97CE6EEB3E9Q57167897-4A782194-FC7A-4D54-A3DF-ECA66A99CDEAQ57526263-F6B44956-B6FD-4A54-918F-30BA2F8A6F0AQ57580028-6F48A4E3-DE2E-46C6-BB38-4E1043AF0655Q58583812-C154A70C-F73A-461E-BBF9-7A0D161C3B2BQ91320191-B0C8DCC6-268A-42E1-9993-980A73806215
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marta Barreto
@ast
Marta Barreto
@en
Marta Barreto
@es
Marta Barreto
@nl
Marta Barreto
@sl
type
label
Marta Barreto
@ast
Marta Barreto
@en
Marta Barreto
@es
Marta Barreto
@nl
Marta Barreto
@sl
altLabel
Marta Barreto da Silva
@en
prefLabel
Marta Barreto
@ast
Marta Barreto
@en
Marta Barreto
@es
Marta Barreto
@nl
Marta Barreto
@sl
P108
P1053
F-5591-2012
P106
P108
P1153
7004455392
P21
P31
P3829
P496
0000-0001-6464-548X